Sign In
Buy KMDA
$7.14
+0.0400 (+0.563%)
At Close: Jul 31, 2026
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy
07:00am, Wednesday, 11'th Mar 2026
REHOVOT, Israel and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.
Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:15am, Friday, 06'th Mar 2026
Besides Wall Street's top-and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
KMDA vs. ARGX: Which Stock Is the Better Value Option?
12:40pm, Thursday, 05'th Mar 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Kamada (KMDA) and argenex SE (ARGX). But which of these two stocks presents investors wi
KMDA or TECH: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 17'th Feb 2026
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Techne (TECH). But which of these two stocks presents investors with the better value opport
Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock?
09:25am, Tuesday, 27'th Jan 2026
Kamada (KMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving Average – Here’s Why
05:12am, Tuesday, 06'th Jan 2026
Kamada Ltd. (NASDAQ: KMDA - Get Free Report)'s share price crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $6.96 and traded as high as
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
07:00am, Thursday, 18'th Dec 2025
REHOVOT, Israel, and HOBOKEN, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Kamada Shuts Down Phase 3 Study For Genetic Condition, Reiterates Outlook
11:05am, Monday, 08'th Dec 2025
Kamada Ltd. (NASDAQ: KMDA) on Monday said it will discontinue its Phase 3 InnovAATe trial of Inhaled AAT for Alpha-1 Antitrypsin Deficiency (AATD).
Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook Transcript
09:26am, Monday, 08'th Dec 2025
Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook Transcript
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average – Time to Sell?
03:32am, Wednesday, 03'rd Dec 2025
Kamada Ltd. (NASDAQ: KMDA - Get Free Report)'s share price crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $7.09 and traded as low as $6.8
Kamada Ltd. (KMDA) Q3 2025 Earnings Call Transcript
10:51am, Monday, 10'th Nov 2025
Kamada Ltd. ( KMDA ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call Participants
Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:30am, Monday, 10'th Nov 2025
While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compar
Kamada (KMDA) Misses Q3 Earnings Estimates
09:16am, Monday, 10'th Nov 2025
Kamada (KMDA) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.07 per share a year ago.
Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth
07:00am, Monday, 10'th Nov 2025
REHOVOT, Israel, and HOBOKEN, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Should Value Investors Buy Kamada (KMDA) Stock?
10:40am, Wednesday, 05'th Nov 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
